Medtronic PLC Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

NYSE
Medtronic plc is offering to exchange newly issued shares of MiniMed Group, Inc. for its own common stock as part of a strategic restructuring.
NYSE
Medtronic plc is offering to exchange newly issued shares of MiniMed Group, Inc. for its own common stock, a move aimed at restructuring its holdings.
NYSE
Medtronic plc is initiating an exchange offer to divest shares of MiniMed Group, Inc. as part of a strategic corporate restructuring.
NYSE
Fidelity informs Medtronic 401(k) plan participants about a voluntary exchange offer for MiniMed shares, with a deadline to provide instructions.
NYSE
Medtronic plc announced an offer to exchange its own common stock for shares of MiniMed Group, Inc., a subsidiary it owns.
NYSE
Medtronic plc has initiated an offer to exchange newly issued shares of MiniMed Group, Inc. for its own common stock, as detailed in a prospectus.
NYSE
Medtronic plc is initiating an exchange offer for its own common stock, distributing shares of its subsidiary, MiniMed Group, Inc.
NYSE
Medtronic plc announces a share exchange offer for its own common stock, involving newly issued shares of MiniMed Group, Inc.
NYSE
MiniMed outlines its strategy for accelerated growth and market leadership in automated insulin delivery following its separation from Medtronic, highlighting product innovation and strong financial performance.
NYSE
Mini-Med has filed a 425 document detailing a strategic split-off transaction aimed at separating its diabetes business into a new, independent entity.
NYSE
Medtronic plc is initiating an exchange offer for MiniMed Group, Inc. shares as part of a strategic restructuring.
NYSE
Medtronic plc is offering to exchange its shares of common stock for newly issued shares of MiniMed Group, Inc. as part of a strategic restructuring.
NYSE
Medtronic plc has filed a Form 8-K to correct a typographical error in the guaranteed delivery procedures for its ongoing exchange offer of MiniMed Group, Inc. common stock.
NYSE
Harry Skip Kiil, EVP & President Cardiovascular of Medtronic plc, sold 1,483 shares of common stock on September 16, 2026 for $93.65 per share.
NYSE
Medtronic's CFO explains the strategic rationale behind spinning off the MiniMed business, citing different business models, lower ROI, and a desire to focus on core, higher-return areas.
NYSE
Medtronic plc is offering to exchange newly issued shares of MiniMed Group, Inc. for its own common stock as part of a strategic restructuring.
NYSE
Denise L. Blomquist, Chief Accounting Officer of Medtronic plc, reported a transaction in 600 shares of common stock on September 15, 2026.
NYSE
Medtronic plc is offering to exchange newly issued shares of MiniMed Group, Inc. for its own common stock as part of a strategic restructuring.
NYSE
Medtronic plc is offering to exchange newly issued shares of its subsidiary, MiniMed Group, Inc., for its own common stock, aiming to unlock value and streamline operations.
NYSE
Medtronic plc has initiated an exchange offer to spin off its remaining equity interest in MiniMed, filing a Form S-4 registration statement with the SEC.
NYSE
MiniMed announces the launch of an exchange offer, marking the final step in its separation from Medtronic and transition to a fully independent public company.
NYSE
MiniMed announces the final major step in its separation from Medtronic, launching an exchange offer for its remaining equity interest to operate as a fully independent company.
NYSE
Medtronic plc announced an exchange offer allowing shareholders to swap Medtronic shares for MiniMed common stock as part of its separation strategy.
NYSE
Medtronic plc has commenced an exchange offer for its shareholders to swap Medtronic ordinary shares for newly issued shares of MiniMed Group, Inc. as part of a divestment plan.
NYSE
Medtronic announced its intention to spin off remaining MiniMed shares through an exchange offer, marking a significant step towards MiniMed's independence.
NYSE
Medtronic announces a share exchange offer allowing shareholders to swap Medtronic shares for MiniMed shares at a discount as part of MiniMed's separation into an independent company.
NYSE
Medtronic plc announced an exchange offer to divest its MiniMed division, aiming to create a more focused Medtronic and an independent leader in diabetes therapies.
NYSE
Medtronic plc is offering its shareholders an exchange of Medtronic ordinary shares for newly issued shares of MiniMed Common Stock to complete the divestment of its Diabetes Operating Unit.
NYSE
Medtronic plc announced an exchange offer allowing shareholders to swap Medtronic shares for MiniMed Group, Inc. stock, aiming for a tax-free separation.
NYSE
MiniMed has filed a Form S-4 Registration Statement for Medtronic's offer to exchange up to 225,361,295 MiniMed shares for outstanding Medtronic ordinary shares, marking a key step towards MiniMed's full separation.